A detailed history of California State Teachers Retirement System transactions in Revance Therapeutics, Inc. stock. As of the latest transaction made, California State Teachers Retirement System holds 94,163 shares of RVNC stock, worth $241,998. This represents 0.0% of its overall portfolio holdings.

Number of Shares
94,163
Previous 97,324 3.25%
Holding current value
$241,998
Previous $250,000 3.6%
% of portfolio
0.0%
Previous 0.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$2.57 - $2.57 $8,123 - $8,123
-3,161 Reduced 3.25%
94,163 $241,000
Q2 2024

Aug 14, 2024

SELL
$2.34 - $4.73 $395 - $799
-169 Reduced 0.17%
97,324 $250,000
Q1 2024

May 15, 2024

BUY
$4.65 - $9.31 $40,306 - $80,699
8,668 Added 9.76%
97,493 $479,000
Q4 2023

Feb 13, 2024

SELL
$5.81 - $11.2 $22,368 - $43,120
-3,850 Reduced 4.15%
88,825 $780,000
Q3 2023

Nov 14, 2023

SELL
$11.47 - $25.07 $101,612 - $222,095
-8,859 Reduced 8.73%
92,675 $1.06 Million
Q2 2023

Aug 21, 2023

SELL
$24.7 - $37.61 $19,315 - $29,411
-782 Reduced 0.76%
101,534 $2.57 Million
Q1 2023

May 09, 2023

SELL
$18.36 - $35.27 $7,931 - $15,236
-432 Reduced 0.42%
102,316 $3.3 Million
Q4 2022

Feb 14, 2023

BUY
$18.32 - $30.66 $89,621 - $149,988
4,892 Added 5.0%
102,748 $1.9 Million
Q3 2022

Nov 18, 2022

BUY
$14.33 - $28.47 $138,169 - $274,507
9,642 Added 10.93%
97,856 $2.64 Million
Q2 2022

Aug 15, 2022

SELL
$11.52 - $20.4 $3,836 - $6,793
-333 Reduced 0.38%
88,214 $1.22 Million
Q1 2022

May 16, 2022

SELL
$12.36 - $20.31 $92,428 - $151,878
-7,478 Reduced 7.79%
88,547 $1.73 Million
Q4 2021

Feb 15, 2022

BUY
$12.46 - $27.87 $31,025 - $69,396
2,490 Added 2.66%
96,025 $1.57 Million
Q3 2021

Nov 15, 2021

SELL
$25.78 - $33.21 $84,145 - $108,397
-3,264 Reduced 3.37%
93,535 $2.61 Million
Q2 2021

Aug 16, 2021

BUY
$26.8 - $31.84 $51,080 - $60,687
1,906 Added 2.01%
96,799 $2.87 Million
Q1 2021

May 18, 2021

SELL
$24.03 - $29.97 $8,843 - $11,028
-368 Reduced 0.39%
94,893 $2.65 Million
Q4 2020

Feb 16, 2021

BUY
$23.41 - $28.34 $608 - $736
26 Added 0.03%
95,261 $2.7 Million
Q3 2020

Nov 17, 2020

BUY
$23.23 - $34.3 $223,240 - $329,623
9,610 Added 11.22%
95,235 $2.39 Million
Q2 2020

Aug 17, 2020

BUY
$12.6 - $26.55 $90,405 - $190,496
7,175 Added 9.15%
85,625 $2.09 Million
Q1 2020

May 13, 2020

BUY
$12.46 - $27.81 $122,506 - $273,427
9,832 Added 14.33%
78,450 $1.16 Million
Q3 2019

Nov 15, 2019

BUY
$10.22 - $14.5 $8,370 - $11,875
819 Added 1.21%
68,618 $892,000
Q2 2019

Aug 14, 2019

BUY
$10.67 - $15.49 $91,143 - $132,315
8,542 Added 14.42%
67,799 $879,000
Q1 2019

May 09, 2019

BUY
$15.4 - $20.39 $121,552 - $160,938
7,893 Added 15.37%
59,257 $934,000
Q4 2018

Feb 13, 2019

BUY
$18.06 - $24.96 $20,913 - $28,903
1,158 Added 2.31%
51,364 $1.03 Million
Q3 2018

Nov 14, 2018

SELL
$23.55 - $30.1 $400 - $511
-17 Reduced 0.03%
50,206 $1.25 Million
Q2 2018

Aug 14, 2018

BUY
$27.45 - $33.35 $253,445 - $307,920
9,233 Added 22.53%
50,223 $1.38 Million
Q1 2018

May 15, 2018

BUY
$29.15 - $37.4 $141,610 - $181,689
4,858 Added 13.45%
40,990 $1.26 Million
Q4 2017

Feb 14, 2018

SELL
$24.55 - $36.3 $9,574 - $14,156
-390 Reduced 1.07%
36,132 $1.29 Million
Q3 2017

Nov 13, 2017

BUY
$22.55 - $28.1 $823,571 - $1.03 Million
36,522
36,522 $1.01 Million

Others Institutions Holding RVNC

About Revance Therapeutics, Inc.


  • Ticker RVNC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 82,305,696
  • Market Cap $212M
  • Description
  • Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials fo...
More about RVNC
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.